Signup to have metrics tracked for this article

By signing up, social media discussions about Comment on 'Efficacy and safety of vismodegib in basosquamous carcinoma: insights from a retrospective study including 18 patients': basosquamous carcinoma at the crossroads: histological ambiguity, treatment potential and the path to clinical consensus. will be collected and displayed on PubHawk. We'll also notify you by email on a monthly basis of any new updates captured on platforms like YouTube, Twitter/X, Bluesky, Facebook, LinkedIn, and more.
Your identifiable personal information will never be sold or shared to directly target you.

Example of Metrics tracking for this article: